A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
2018 ◽
Vol 18
(5)
◽
pp. 346-352.e5
◽
2012 ◽
Vol 53
(7)
◽
pp. 1331-1337
◽
2016 ◽
Vol 22
(4)
◽
pp. 698-704
◽
2019 ◽
Vol 55
(2)
◽
pp. 452-460
◽
2003 ◽
Vol 27
(10)
◽
pp. 893-897
◽